Jerrold Levy
#89,859
Most Influential Person Now
American critical care physician and cardiac anesthesiologist
Jerrold Levy's AcademicInfluence.com Rankings
Jerrold Levyphilosophy Degrees
Philosophy
#3634
World Rank
#5839
Historical Rank
#1139
USA Rank
Logic
#1292
World Rank
#2004
Historical Rank
#395
USA Rank
Download Badge
Philosophy
Jerrold Levy's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Physiology University of California, San Francisco
Why Is Jerrold Levy Influential?
(Suggest an Edit or Addition)According to Wikipedia, Jerrold H. Levy is an American critical care physician and cardiac anesthesiologist at Duke University Medical Center who currently serves as the co-director of Duke's Cardiothoracic Intensive Care Unit. He is most noted for his research in surgical hemostasis, coagulopathy in the critically ill, shock, anaphylaxis, and developing purified and recombinant therapeutic approaches to treat bleeding. He has authored over 400 publications, including scientific manuscripts, review articles, editorials, books, and book chapters. Additionally, he has authored a number of websites aimed at providing medical information to healthcare professionals through his website, DocMD.
Jerrold Levy's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- COVID-19 and its implications for thrombosis and anticoagulation (2020) (1862)
- Coagulation abnormalities and thrombosis in patients with COVID-19 (2020) (1109)
- Idarucizumab for Dabigatran Reversal. (2015) (1093)
- Symposium on the definition and management of anaphylaxis: summary report. (2005) (638)
- Idarucizumab for Dabigatran Reversal — Full Cohort Analysis (2017) (612)
- Thromboinflammation and the hypercoagulability of COVID‐19 (2020) (534)
- Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID‐19 (2020) (498)
- Guidelines for Perioperative Care in Cardiac Surgery: Enhanced Recovery After Surgery Society Recommendations. (2019) (426)
- Effects of red-cell storage duration on patients undergoing cardiac surgery. (2015) (402)
- Safety of recombinant activated factor VII in randomized clinical trials. (2010) (388)
- Coagulopathy of Coronavirus Disease 2019 (2020) (370)
- The unique characteristics of COVID-19 coagulopathy (2020) (342)
- Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference (2019) (320)
- Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes (2004) (313)
- Blood Coagulation: Hemostasis and Thrombin Regulation (2009) (311)
- A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting. (1995) (301)
- Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation (2019) (283)
- Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis (2018) (276)
- Coagulopathy in COVID‐19 (2020) (268)
- Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. (1999) (267)
- When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH (2016) (267)
- Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. (1998) (258)
- Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy (2014) (257)
- The coagulopathy, endotheliopathy, and vasculitis of COVID-19 (2020) (252)
- Fibrinogen and Hemostasis: A Primary Hemostatic Target for the Management of Acquired Bleeding (2012) (248)
- The inflammatory response to cardiopulmonary bypass. (2003) (245)
- Inflammatory response to cardiopulmonary bypass. (1997) (234)
- Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. (2009) (232)
- Concepts of blood transfusion in adults (2013) (224)
- Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery (2017) (213)
- New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey (2017) (204)
- The ECLIPSE Trials: Comparative Studies of Clevidipine to Nitroglycerin, Sodium Nitroprusside, and Nicardipine for Acute Hypertension Treatment in Cardiac Surgery Patients (2008) (201)
- Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. (2001) (196)
- Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial. (2004) (196)
- Comparison of three‐factor and four‐factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers (2014) (195)
- Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. (2011) (189)
- Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. (2002) (187)
- Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis. (2012) (176)
- Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting (2013) (165)
- The Use of Bovine Hemoglobin Glutamer-250 (Hemopure®) in Surgical Patients: Results of a Multicenter, Randomized, Single-Blinded Trial (2002) (164)
- Predicting and Treating Coagulopathies After Cardiopulmonary Bypass in Children (1997) (163)
- Extracorporeal Membrane Oxygenation in the Adult: A Review of Anticoagulation Monitoring and Transfusion (2014) (159)
- Perioperative Hemostatic Management of Patients Treated with Vitamin K Antagonists (2008) (158)
- Derangement of the endothelial glycocalyx in sepsis (2019) (155)
- Increasing cardiopulmonary resuscitation provision in communities with low bystander cardiopulmonary resuscitation rates: a science advisory from the American Heart Association for healthcare providers, policymakers, public health departments, and community leaders. (2013) (145)
- Multidisciplinary Approach to the Challenge of Hemostasis (2010) (143)
- Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran (2015) (139)
- A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution‐induced coagulation changes after cardiac surgery (2012) (138)
- Cryoprecipitate therapy (2014) (133)
- Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation (2019) (127)
- Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). (2010) (125)
- Protamine Reversal of Heparin Affects Platelet Aggregation and Activated Clotting Time After Cardiopulmonary Bypass (1998) (118)
- Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring (2020) (116)
- Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. (2005) (116)
- Evaluation of patients at risk for protamine reactions. (1989) (115)
- Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven). (2003) (115)
- Antifibrinolytic therapy: new data and new concepts (2010) (114)
- Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. (2016) (114)
- A Phase III, Double-blind, Placebo-controlled, Multicenter Study on the Efficacy of Recombinant Human Antithrombin in Heparin-resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass (2005) (112)
- How I use fibrinogen replacement therapy in acquired bleeding. (2015) (112)
- Reversal agents for non-vitamin K antagonist oral anticoagulants (2018) (111)
- Antithrombin: anti-inflammatory properties and clinical applications (2015) (109)
- Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage. (2010) (109)
- Heparin-induced thrombocytopenia and cardiac surgery (2010) (108)
- Anaphylaxis During Cardiac Surgery: Implications for Clinicians (2008) (107)
- Determination of the Hemodynamics and Histamine Release of Rocuronium (Org 9426) When Administered in Increased Doses Under N[2]O/O[2]‐Sufentanil Anesthesia (1994) (106)
- Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries. (1999) (105)
- Rapid Evaluation of Coagulopathies After Cardiopulmonary Bypass in Children Using Modified Thromboelastography (2000) (103)
- Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile (2006) (103)
- The Effects of Platelet Count on Clot Retraction and Tissue Plasminogen Activator-Induced Fibrinolysis on Thrombelastography (2005) (103)
- Clevidipine Effectively and Rapidly Controls Blood Pressure Preoperatively in Cardiac Surgery Patients: The Results of the Randomized, Placebo-Controlled Efficacy Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery-1 (2007) (102)
- Advance in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation (2019) (100)
- Perioperative management of the bleeding patient. (2016) (100)
- Mechanisms of Nonimmunological Histamine and Tryptase Release from Human Cutaneous Mast Cells (2000) (100)
- Wheal and flare responses to opioids in humans. (1989) (100)
- Weal and flare responses to intradermal rocuronium and cisatracurium in humans. (2000) (95)
- Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation. (2008) (94)
- Bleeding and management of coagulopathy. (2011) (92)
- Prospective Evaluation of Risk of Protamine Reactions in Patients with NPH Insulin‐Dependent Diabetes (1986) (92)
- Bacterial contamination of platelets for transfusion: strategies for prevention (2018) (91)
- Impact of percutaneous coronary intervention performance reporting on cardiac resuscitation centers: a scientific statement from the American Heart Association. (2013) (90)
- Pharmacokinetics of Aprotinin in Preoperative Cardiac Surgical Patients (1994) (89)
- Massive transfusion coagulopathy. (2006) (89)
- Functional Maturity of the Coagulation System in Children: An Evaluation Using Thrombelastography (1997) (88)
- Antifibrinolytic Therapy and Perioperative Considerations. (2017) (87)
- Anaphylactic Reactions in Anesthesia and Intensive Care (1986) (87)
- Updates in the perioperative and emergency management of non-vitamin K antagonist oral anticoagulants (2015) (83)
- Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO (2020) (82)
- Platelet Counts, Acute Kidney Injury, and Mortality after Coronary Artery Bypass Grafting Surgery (2016) (82)
- Prothrombin complex concentrates in trauma and perioperative bleeding. (2015) (81)
- Biology of Factor XIII and clinical manifestations of Factor XIII deficiency (2013) (80)
- Direct oral anticoagulants: new drugs and new concepts. (2014) (79)
- Pharmacologic preservation of the hemostatic system during cardiac surgery. (2001) (79)
- The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema (2006) (79)
- Inadvertent transbronchial insertion of narrow-bore feeding tubes into the pleural space. (1984) (79)
- Antifibrinolytic Therapy for Cardiac Surgery: An Update. (2015) (78)
- Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial. (2013) (78)
- Anticoagulation Monitoring during Cardiac Surgery (1999) (78)
- Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials. (2011) (78)
- Adult extracorporeal membrane oxygenation: an international survey of transfusion and anticoagulation techniques (2017) (76)
- Novel Oral Anticoagulants: Implications in the Perioperative Setting (2010) (75)
- Intravenous milrinone in cardiac surgery. (2002) (73)
- Proposal of the Definition for COVID-19-Associated Coagulopathy (2021) (72)
- Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting (2016) (71)
- Novel oral anticoagulants and reversal agents: Considerations for clinical development. (2015) (71)
- Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing. (2014) (70)
- Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (1998) (69)
- Clevidipine in Adult Cardiac Surgical Patients: A Dose-finding Study (2002) (69)
- The Effect of Milrinone on Hemodynamics and Left Ventricular Function After Emergence from Cardiopulmonary Bypass (1997) (68)
- Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial. (1996) (67)
- Prevention and treatment of coagulopathy in patients receiving massive transfusions (2011) (66)
- Improved Clot Formation by Combined Administration of Activated Factor VII (NovoSeven®) and Fibrinogen (Haemocomplettan® P) (2008) (66)
- Does Perioperative Systolic Blood Pressure Variability Predict Mortality After Cardiac Surgery? An Exploratory Analysis of the ECLIPSE trials (2011) (66)
- Association of Myocardial Enzyme Elevation and Survival Following Coronary Artery Bypass Graft Surgery (2012) (65)
- Thrombomodulin in disseminated intravascular coagulation and other critical conditions—a multi-faceted anticoagulant protein with therapeutic potential (2019) (65)
- Histamine release by vancomycin: a mechanism for hypotension in man. (1987) (64)
- A Phase II, Double-Blind, Placebo-Controlled, Ascending-Dose Study of Eritoran (E5564), a Lipid A Antagonist, in Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass (2007) (64)
- Heparin Neutralization by Recombinant Platelet Factor 4 and Protamine (1995) (60)
- Unlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel. (2000) (58)
- Adenosine A3-receptor stimulation attenuates postischemic dysfunction through KATP channels. (1999) (57)
- Heparin Neutralization with Methylene Blue, Hexadimethrine, or Vancomycin After Cardiopulmonary Bypass (1996) (57)
- Andexanet alfa for the reversal of Factor Xa inhibitor related anticoagulation (2016) (56)
- The In Vitro Effects of Antithrombin III on the Activated Coagulation Time in Patients on Heparin Therapy (2000) (55)
- The human inflammatory response. (1996) (55)
- Differential diagnoses for sepsis‐induced disseminated intravascular coagulation: communication from the SSC of the ISTH (2019) (55)
- Clopidogrel (Plavix®) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding (2004) (54)
- Relationship between clinical evaluation of peripheral perfusion and global hemodynamics in adults after cardiac surgery (1990) (54)
- Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization (2007) (52)
- Anaphylaxis to meperidine. (1982) (52)
- ISTH DIC subcommittee communication on anticoagulation in COVID‐19 (2020) (52)
- Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. (1994) (50)
- In reply (2014) (49)
- The Effects of Milrinone on Platelets in Patients Undergoing Cardiac Surgery (1995) (48)
- Heparin-induced thrombocytopenia, a prothrombotic disease. (2007) (47)
- Recombinant Human Transgenic Antithrombin in Cardiac Surgery: A Dose-finding Study (2002) (47)
- Anticoagulation management during cardiopulmonary bypass: a survey of 54 North American institutions. (2010) (47)
- Enhanced Recovery After Cardiac Surgery (ERAS Cardiac) Recommendations: An Important First Step-But There Is Much Work to Be Done. (2019) (45)
- Repletion of factor XIII following cardiopulmonary bypass using a recombinant A-subunit homodimer (2009) (45)
- Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality (2020) (45)
- ISTH guidelines for antithrombotic treatment in COVID‐19 (2022) (45)
- A Diagnosis of Heparin-Induced Thrombocytopenia with Combined Clinical and Laboratory Methods in Cardiothoracic Surgical Intensive Care Unit Patients (2011) (45)
- Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation (2016) (45)
- Early experience with activated recombinant factor VII for intractable hemorrhage after cardiovascular surgery. (2005) (45)
- Prevention of chronic cerebral vasospasm in dogs with milrinone. (1997) (45)
- Argatroban and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery (2017) (45)
- Pharmacokinetics of amrinone during cardiac surgery. (1991) (44)
- Effect of pexelizumab on mortality in patients with acute myocardial infarction or undergoing coronary artery bypass surgery: a systematic overview. (2006) (44)
- The In Vitro Effects of Phosphodiesterase Inhibitors on the Human Internal Mammary Artery (1996) (44)
- Hereditary Angioedema: Current and Emerging Treatment Options (2010) (44)
- Perioperative blood pressure control: a prospective survey of patient management in cardiac surgery. (2000) (43)
- Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia (2021) (43)
- Hemostatic agents (2004) (43)
- Reducing Thrombotic Complications in the Perioperative Setting: An Update on Heparin-Induced Thrombocytopenia (2007) (43)
- Pharmacologic methods to reduce perioperative bleeding (2008) (43)
- Discontinuation and management of direct-acting anticoagulants for emergency procedures. (2016) (43)
- A double-blind, placebo-controlled trial of epsilon-aminocaproic acid for reducing blood loss in coronary artery bypass grafting surgery. (2006) (42)
- The progression from coagulopathy to disseminated intravascular coagulation in representative underlying diseases. (2019) (41)
- Antithrombin Deficiency Increases Thrombin Activity After Prolonged Cardiopulmonary Bypass (2008) (41)
- The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran (2017) (40)
- The effects of rapacuronium on histamine release and hemodynamics in adult patients undergoing general anesthesia. (1999) (40)
- Heparin Resistance - Clinical Perspectives and Management Strategies. (2021) (40)
- Sepsis-induced Coagulopathy and Disseminated Intravascular Coagulation (2020) (40)
- Full-Dose Aprotinin Use in Coronary Artery Bypass Graft Surgery: An Analysis of Perioperative Pharmacotherapy and Patient Outcomes (2006) (39)
- TREATMENT OF PERIOPERATIVE HYPERTENSION (1999) (39)
- Defining trauma‐induced coagulopathy with respect to future implications for patient management: Communication from the SSC of the ISTH (2020) (39)
- 229 (2019) (39)
- Pharmacodynamics and Pharmacokinetics of Milrinone Administration to Increase Oxygen Delivery in Critically III Patients (1996) (39)
- Does moderate hypothermia really carry less bleeding risk than deep hypothermia for circulatory arrest? A propensity-matched comparison in hemiarch replacement. (2016) (39)
- Point of Care and Factor Concentrate-Based Coagulation Algorithms (2015) (38)
- Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time. (2006) (38)
- Thrombin Generation Assay and Viscoelastic Coagulation Monitors Demonstrate Differences in the Mode of Thrombin Inhibition Between Unfractionated Heparin and Bivalirudin (2007) (38)
- The Effects of Argatroban on Thrombin Generation and Hemostatic Activation In Vitro (2004) (38)
- Heparinase I (Neutralase) Reversal of Systemic Anticoagulation (1996) (37)
- Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. (2020) (37)
- Idarucizumab for dabigatran overdose (2016) (37)
- The Plasma Supplemented Modified Activated Clotting Time for Monitoring of Heparinization During Cardiopulmonary Bypass: A Pilot Investigation (2002) (37)
- Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: A randomised, controlled study (2014) (36)
- Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia. (2005) (36)
- Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery. (2006) (36)
- Patient Blood Management: Effectiveness and Future Potential. (2008) (36)
- Point of care devices for assessing bleeding and coagulation in the trauma patient. (2013) (35)
- Evaluation and management of bleeding during cardiac surgery. (2005) (35)
- The In Vitro Reversal of Histamine-Induced Vasodilation in the Human Internal Mammary Artery (2001) (35)
- Rivaroxaban reversal with prothrombin complex concentrate or tranexamic acid in healthy volunteers (2018) (34)
- Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis. (2018) (33)
- A Comparative Evaluation of the Effects of Multiple Vasodilators on Human Internal Mammary Artery (1998) (33)
- Anticoagulation strategies for the management of postoperative atrial fibrillation. (2014) (33)
- A phase 2 prospective, randomized, double-blind trial comparing the effects of tranexamic acid with ecallantide on blood loss from high-risk cardiac surgery with cardiopulmonary bypass (CONSERV-2 Trial). (2012) (33)
- Treatment of persistent tachycardia with dexmedetomidine during off-pump cardiac surgery. (2002) (32)
- Is preoperative fibrinogen predictive for postoperative bleeding after coronary artery bypass grafting surgery? (2009) (32)
- The Anticoagulant Effect of Protamine Sulfate Is Attenuated in the Presence of Platelets or Elevated Factor VIII Concentrations (2010) (32)
- Treatment of postoperative hypertension after coronary artery bypass surgery. Double-blind comparison of intravenous isradipine and sodium nitroprusside. (1994) (32)
- Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin. (2008) (32)
- Anaphylactic/anaphylactoid reactions during cardiac surgery. (1989) (32)
- Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review (2021) (30)
- Pathophysiological Response to Trauma-Induced Coagulopathy: A Comprehensive Review (2020) (30)
- Hemostatic agents and their safety. (1999) (30)
- Pharmacokinetics and pharmacodynamics of phosphodiesterase-III inhibitors (1990) (30)
- Tissue Factor-Activated Thromboelastograms in Children Undergoing Cardiac Surgery: Baseline Values and Comparisons (2003) (30)
- Aprotinin: a pharmacologic overview. (2004) (29)
- The use of haemoglobin glutamer-250 (HBOC-201) as an oxygen bridge in patients with acute anaemia associated with surgical blood loss (2003) (29)
- Increased anticoagulation during cardiopulmonary bypass by aprotinin. (1991) (29)
- Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII. (2008) (29)
- Pexelizumab reduces death and myocardial infarction in higher risk cardiac surgical patients. (2006) (28)
- Recombinant antithrombin: production and role in cardiovascular disorder. (2001) (28)
- Inflammation and cardiopulmonary bypass (1993) (28)
- The ideal agent for perioperative hypertension and potential cytoprotective effects (1993) (28)
- Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH (2018) (27)
- Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial (2016) (27)
- The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic thrombocytopenia (2021) (27)
- Complement Activation and Cardiac Surgery: A Novel Target for Improving Outcomes (2012) (27)
- Activated recombinant factor VII in cardiac surgery (2005) (27)
- Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors (2007) (27)
- Noninvasive detection of periinduction ischemic ventricular dysfunction by cardiokymography in humans: preliminary experience. (1984) (26)
- In vitro comparative study of hemostatic components in warfarin-treated and fibrinogen-deficient plasma. (2010) (26)
- Pharmacokinetics of Recombinant Transgenic Antithrombin in Volunteers (2000) (26)
- Pharmacokinetics of Intravenous Milrinone in Patients Undergoing Cardiac Surgery (1994) (26)
- Recent advances in the research and management of sepsis-associated DIC (2021) (26)
- The role of thrombin and protease-activated receptors in pain mechanisms (2010) (25)
- Therapeutic Plasma Transfusion in Bleeding Patients: A Systematic Review (2017) (25)
- Amrinone: pharmacokinetics and pharmacodynamics. (1989) (24)
- Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia (2021) (24)
- The Judicious Use of Recombinant Factor VIIa (2016) (24)
- Perioperative management of patients receiving new oral anticoagulants: an international survey. (2014) (24)
- Safe application of a restrictive transfusion protocol in moderate-risk patients undergoing cardiac operations. (2014) (23)
- Anaphylaxis. What is monitored to make a diagnosis? How is therapy monitored? (2001) (23)
- Anaphylactic reactions to neuromuscular blocking drugs: are we making the correct diagnosis? (2004) (23)
- The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review (2018) (23)
- Peer Review Matters: Research Quality and the Public Trust. (2021) (23)
- Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery (2007) (23)
- Sepsis-Induced Coagulopathy and Japanese Association for Acute Medicine DIC in Coagulopathic Patients with Decreased Antithrombin and Treated by Antithrombin (2018) (23)
- Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux. (2011) (22)
- Coagulopathy After Cardiopulmonary Bypass in Jehovah’s Witness Patients: Management of Two Cases Using Fractionated Components and Factor VIIa (2007) (22)
- DOES APROTININ INHIBIT CARDIOPULMONARY BYPASSINDUCED INFLAMMATION (1992) (22)
- Management of systemic and pulmonary hypertension. (2005) (22)
- Wheal and flare responses to muscl relaxants in humans (1991) (21)
- Anticoagulation management associated with extracorporeal circulation. (2015) (21)
- Fibrinogen and bleeding: old molecule--new ideas. (2007) (21)
- Goal-directed coagulation management in the perioperative period of cardiac surgery. (2013) (21)
- Regulation of thrombin activity--pharmacologic and structural aspects. (2007) (21)
- Efficacy and safety of aprotinin in cardiac surgery. (2004) (21)
- Factor Xa induces tissue factor expression in endothelial cells by P44/42 MAPK and NF-κB-dependent pathways. (2011) (21)
- Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis (2019) (21)
- Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation (2019) (21)
- Prothrombin Complex Concentrates for Perioperative Vitamin K Antagonist and Non–vitamin K Anticoagulant Reversal (2018) (21)
- Managing clotting: a North American perspective (2012) (21)
- The Vasodilator Effects of Clevidipine on Human Internal Mammary Artery (1997) (21)
- Proposal of a two‐step process for the diagnosis of sepsis‐induced disseminated intravascular coagulation (2019) (20)
- Perioperative anaphylaxis and the United States perspective. (2011) (20)
- The influence of red wine or white wine intake on platelet function and viscoelastic property of blood in volunteers (2004) (20)
- COVID‐19: Thrombosis, thromboinflammation, and anticoagulation considerations (2021) (20)
- HIT happens: diagnosing and evaluating the patient with heparin-induced thrombocytopenia. (2008) (20)
- A hemorrhage of off-label use. (2011) (20)
- A Step Toward Balance: Thrombin Generation Improvement via Procoagulant Factor and Antithrombin Supplementation (2016) (20)
- The Immunologic Effect of Early Intravenous Two and Four Gram Bolus Dosing of Tranexamic Acid Compared to Placebo in Patients With Severe Traumatic Bleeding (TAMPITI): A Randomized, Double-Blind, Placebo-Controlled, Single-Center Trial (2020) (20)
- Use of cardiopulmonary bypass in studies of the circulation. (1988) (19)
- Development and implementation of common data elements for venous thromboembolism research: on behalf of SSC Subcommittee on official Communication from the SSC of the ISTH (2020) (19)
- Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal (2016) (19)
- Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients. (1996) (19)
- Hemostasis and Cardiopulmonary Bypass (1995) (19)
- Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit. (2012) (19)
- Anaphylactic and Anaphylactoid Reactions: A Review (1986) (19)
- Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations (2020) (19)
- Adenosine A(3)-receptor stimulation attenuates postischemic dysfunction through K(ATP) channels. (1999) (19)
- Case 3--1999. Intraoperative coronary thrombosis in association with low-dose aprotinin therapy. (1999) (18)
- Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis. (2013) (18)
- New oral anticoagulant-induced bleeding: clinical presentation and management. (2014) (18)
- Thrombin generation and fibrinolysis in anti‐factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa (2009) (18)
- What is blood and what is not? Caring for the Jehovah's Witness patient undergoing cardiac surgery. (2007) (18)
- Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery (2019) (18)
- Anti-inflammatory strategies and hemostatic agents: old drugs, new ideas. (2007) (18)
- The Developing Balance of Thrombosis and Hemorrhage in Pediatric Surgery: Clinical Implications of Age-Related Changes in Hemostasis (2020) (18)
- Antibody formation after drug administration during cardiac surgery: parameters for aprotinin use. (1993) (18)
- Commentary: recombinant activated factor VII: the controversial conundrum regarding its off-label use. (2011) (17)
- Antithrombin Affects Hemostatic Response to Recombinant Activated Factor VII in Factor VIII Deficient Plasma (2008) (17)
- Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro. (2004) (17)
- A Novel Method to Assess Platelet Inhibition by Eptifibatide with Thrombelastograph® (2004) (17)
- The influence of various patient characteristics on D-dimer concentration in critically ill patients and its role as a prognostic indicator in the intensive care unit setting. (2014) (17)
- Horseshoe Crab Aquaculture as a Sustainable Endotoxin Testing Source (2020) (17)
- In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition (2010) (17)
- Sepsis-induced disseminated intravascular coagulation, symmetrical peripheral gangrene, and amputations. (2013) (17)
- Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline. (2022) (17)
- Effect of intravenous lidocaine on the transcerebral inflammatory response during cardiac surgery: a randomized-controlled trial (2016) (17)
- Impact of perioperative blood pressure variability on health resource utilization after cardiac surgery: an analysis of the ECLIPSE trials. (2014) (16)
- What is the evidence for platelet transfusion in perioperative settings? (2017) (16)
- Activated clotting times, heparin responses, and antithrombin: have we been wrong all these years? (2010) (16)
- Contamination reduction during central venous catheterization. (1988) (16)
- Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan (2005) (16)
- Novel intravenous antithrombins. (2001) (16)
- Warfarin therapy does not increase bleeding in patients undergoing heart transplantation. (2001) (16)
- 3-Factor Prothrombin Complex Concentrates in Infants With Refractory Bleeding After Cardiac Surgery. (2016) (15)
- Anti-factor IXa Aptamer reduces propagation of thrombin generation in plasma anticoagulated with warfarin. (2010) (15)
- Eptifibatide‐induced thrombocytopenia and coronary bypass operation (2003) (15)
- Prohemostatic Treatment in Cardiac Surgery (2012) (15)
- Guidelines for Perioperative Blood Transfusion and Conservation in Cardiac Surgery: Lessons and Challenges (2010) (15)
- In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry (2009) (15)
- Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination (2022) (15)
- New concepts in the treatment of anaphylactoid reactions in anesthesia. (1993) (15)
- Vancomycin and adverse drug reactions. (1993) (15)
- The influence of hyperglycemia on neutrophil extracellular trap formation and endothelial glycocalyx damage in a mouse model of type 2 diabetes. (2020) (15)
- In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel. (2013) (15)
- Diagnosis and treatment of anaphylactic/anaphylactoid reactions. (1992) (15)
- Heparin resistance and antithrombin: should it still be called heparin resistance? (2004) (14)
- Evaluation of dynamic parameters of thrombus formation measured on whole blood using rotational thromboelastometry in children undergoing cardiac surgery: a descriptive study (2015) (14)
- Concentration-Dependent Dual Role of Thrombin in Protection of Cultured Rat Cortical Neurons (2015) (14)
- Etiology and Assessment of Hypercoagulability with Lessons from Heparin-Induced Thrombocytopenia (2011) (14)
- In vitro effects of antihypertensive drugs on thromboxane agonist (U46619)-induced vasoconstriction in human internal mammary artery. (2004) (14)
- The effect of aprotinin on activated protein C‐mediated downregulation of endogenous thrombin generation (2006) (14)
- Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered? (2021) (14)
- Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH (2020) (13)
- Controlled Multifactorial Coagulopathy: Effects of Dilution, Hypothermia, and Acidosis on Thrombin Generation In Vitro (2020) (13)
- Three‐factor prothrombin complex concentrates for refractory bleeding after cardiovascular surgery within an algorithmic approach to haemostasis (2019) (13)
- Ischemic limb necrosis in septic shock: What is the role of high‐dose vasopressor therapy? (2019) (13)
- Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy (2021) (13)
- Transfusion and hemostasis in cardiac surgery (2008) (13)
- Periprocedural antiplatelet therapy: recommendations for standardized reporting in patients on antiplatelet therapy: communication from the SSC of the ISTH (2013) (13)
- Prediction of Early Death in Patients With Sepsis-Associated Coagulation Disorder Treated With Antithrombin Supplementation (2018) (13)
- Amrinone: its effect on vascular resistance and capacitance in human subjects. (1994) (12)
- Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for VTE prophylaxis? (2012) (12)
- Treating shock--old drugs, new ideas. (2010) (12)
- Hemoglobin-based oxygen-carrying solutions: close but still so far. (2000) (12)
- Anaphylactic reactions (1992) (12)
- Randomized evaluation of fibrinogen versus placebo in complex cardiovascular surgery: post hoc analysis and interpretation of phase III results. (2018) (12)
- Management strategies for high-risk cardiac surgery: improving outcomes in patients with heart failure. (2000) (12)
- Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study (2017) (12)
- EVALUATION OF HISTAMINE RELEASE FOLLOWING ORG 9426 ADMINISTRATION USING A NEW RADIOIMMUNOASSAY (1991) (12)
- Prohemostatic agents to prevent perioperative blood loss. (2008) (12)
- A Case Series of Recombinant Platelet Factor 4 for Heparin Reversal After Cardiopulmonary Bypass (2012) (12)
- Overview of clinical efficacy and safety of pharmacologic strategies for blood conservation. (2005) (12)
- Heatstroke-induced coagulopathy: Biomarkers, mechanistic insights, and patient management (2022) (12)
- Perioperative coagulation management in the intensive care unit (2013) (12)
- The anticoagulated patient: strategies for effective blood loss management. (2007) (11)
- Allergic reactions during anesthesia. (1988) (11)
- Protocol adherence when managing massive bleeding following complex cardiac surgery: a study design pilot. (2015) (11)
- Algorithm-based management of bleeding in patients with extracorporeal membrane oxygenation (2013) (11)
- Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation (2008) (11)
- Aprotinin in cardiac surgery. (2006) (11)
- Recommended Primary Outcomes for Clinical Trials Evaluating Hemostatic Blood Products and Agents in Patients with Bleeding: Proceedings of a National Heart Lung and Blood Institute and United States Department of Defense Consensus Conference. (2021) (11)
- Adverse reactions to protamine. (1993) (11)
- CURRENT TOPICS IN PULMONARY PHARMACOLOGY AND TOXICOLOGY (1988) (11)
- Safety of aprotinin in heparinized and nonheparinized patients. (2004) (11)
- Anesthetic concerns for patients with coagulopathy (2010) (11)
- Technology: Is There Sufficient Evidence to Change Practice in Point-of-Care Management of Coagulopathy? (2017) (11)
- Effects of tirofiban on haemostatic activation in vitro. (2004) (11)
- Discontinuation and Management of Direct-Acting Anticoagulants for Emergency Procedures. (2016) (10)
- H1 AND H2 HISTAMINE RECEPTORS. Edited by GUY A. SETTIPANE. (1989) (10)
- Underlying disorders of disseminated intravascular coagulation: Communication from the ISTH SSC Subcommittees on Disseminated Intravascular Coagulation and Perioperative and Critical Care Thrombosis and Hemostasis (2020) (10)
- Management of Surgical Hemostasis: Systemic Agents: (2008) (10)
- New Cardiac Drugs (1995) (10)
- Should aprotinin continue to be used during cardiac surgery? (2006) (10)
- Novel pharmacologic approaches to reduce bleeding. (2003) (10)
- The Vasodilatory Effects of Hydralazine, Nicardipine, Nitroglycerin, and Fenoldopam in the Human Umbilical Artery (2003) (9)
- Aspirin and bleeding after coronary artery bypass grafting. (1994) (9)
- Platelet inhibitors and bleeding in cardiac surgical patients. (2000) (9)
- Anticoagulation and reversal paradigms: is too much of a good thing bad? (2009) (9)
- Protamine, is something fishy about it? The spectre of anaphylaxis continues. (2019) (9)
- Efficacité et sécurité de l’acide tranexamique en prévention et/ou en traitement de l’hémorragie du post-partum : une revue systématique de la littérature avec méta-analyse (2014) (9)
- Viscoelastic Coagulation Testing: Use and Current Limitations in Perioperative Decision-making. (2021) (9)
- Postoperative Cardiovascular Management (2008) (9)
- Heparin resistance and the potential impact on maintenance of therapeutic coagulation (2007) (9)
- 4 – Complement and Contact Activation (1992) (8)
- Case 4-2007. Aprotinin-induced cardiovascular collapse after a negative test dose in a patient scheduled for repeat mitral valve surgery. (2007) (8)
- Suspected protamine allergy: diagnosis and management for coronary artery surgery. (1994) (8)
- PHOSPHODIESTERASE INHIBITORS DILATE HUMAN INTERNAL MAMMARY ARTERY IN VITRO (1991) (8)
- Support of the perioperative failing heart with preexisting ventricular dysfunction: currently available options. (1993) (8)
- [Efficacy and safety of tranexamic acid administration for the prevention and/or the treatment of post-partum haemorrhage: a systematic review with meta-analysis]. (2014) (8)
- VASCULAR EFFECTS OF ORG9487 IN HUMAN MAMMARY ARTERIES, A NEW SHORT ACTING MUSCLE RELAXANT (1998) (8)
- What Is the PROPPR Transfusion Strategy in Trauma Resuscitation? (2016) (8)
- Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm? (2021) (8)
- Aprotinin versus tranexamic acid: the controversy continues (2006) (8)
- Phosphodiesterase inhibitors: the inotropes of choice for the new millennium? (2000) (8)
- Andexanet Alfa Use in Patients Requiring Cardiopulmonary Bypass: Quo Vadis? (2019) (7)
- The role of platelets in heat-related illness and heat-induced coagulopathy. (2022) (7)
- Pharmacology and safety of new oral anticoagulants: the challenge of bleeding persists. (2014) (7)
- The relationship between the reinfusion of shed blood and stroke in coronary artery bypass grafting patients (2000) (7)
- Abstract 10881: Mortality Benefit with Prasugrel in TRITON - TIMI 38 Coronary Artery Bypass Grafting (CABG) Cohort: Risk Adjusted Retrospective Data Analysis (2010) (7)
- Newly Developed Recombinant Antithrombin Protects the Endothelial Glycocalyx in an Endotoxin-Induced Rat Model of Sepsis (2020) (7)
- Hemoglobin-based oxygen carriers for reversing hypotension and shock: "NO" way, "NO" how? (2011) (7)
- Using Plasma and Prothrombin Complex Concentrates (2019) (7)
- Procedimientos de cuidados intensivos posoperatorios del Massachusetts General Hospital (1990) (7)
- Therapeutic strategies in patients with coagulopathy and disseminated intravascular coagulation: awareness of the phase-dependent characteristics. (2021) (7)
- Anaphylaxis during anesthesia. (1991) (7)
- Quantitative assessment of fibrinogen cross‐linking by ϵaminocaproic acid in patients with end‐stage liver disease (2004) (7)
- Editorial commentary: Vascular injury in acute infections and COVID-19: everything old is new again (2020) (7)
- Management of surgical hemostasis: systemic agents. (2008) (7)
- IDARUCIZUMAB FOR REVERSAL OF THE ANTICOAGULANT EFFECTS OF DABIGATRAN IN PATIENTS IN AN EMERGENCY SETTING OF MAJOR BLEEDING, URGENT SURGERY, OR INTERVENTIONS (2016) (6)
- Authorship and Publication Matters: Credit and Credibility (2021) (6)
- Precision Correction of Coagulopathy or Prothrombin Complex Concentrates?: Reversal Options for Dabigatran following Trauma. (2017) (6)
- The Effects of MDCO-2010, a Serine Protease Inhibitor, on Activated Clotting Time in Blood Obtained from Volunteers and Cardiac Surgical Patients (2012) (6)
- Diagnosing heparin-induced thrombocytopenia in cardiac surgical patients: not as easy as you think. (2011) (6)
- Endothelial Injury in COVID-19 and Acute Infections: Putting the Pieces of the Puzzle Together. (2021) (6)
- Viral-Induced Inflammatory Coagulation Disorders: Preparing for Another Epidemic (2021) (6)
- Disseminated Intravascular Coagulation: The Past, Present, and Future Considerations. (2022) (6)
- Fibrin-modulating nanogels for treatment of disseminated intravascular coagulation. (2021) (6)
- Anaphylactic reactions in cardiac surgical patients: Et tu, Brute? (2001) (6)
- Quantitative assessment of fibrinogen cross-linking by epsilon aminocaproic acid in patients with end-stage liver disease. (2004) (6)
- Predicting mortality in patients with disseminated intravascular coagulation after cardiopulmonary bypass surgery by utilizing two scoring systems (2019) (6)
- Tranexamic Acid for Acute Hemorrhage: When Is Enough Evidence Enough? (2019) (6)
- Platelet inhibitors and cardiac surgery. (2000) (6)
- In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonists c7E3 Fab on the activated clotting time. (1997) (6)
- Effects of protamine on histamine release from human lung (1985) (6)
- Initial experience with idarucizumab in dabigatran-treated patients requiring emergency surgery or interventon: interim results from the RE-VERSE AD study (2015) (6)
- Anaphylaxis and Adverse Drug Reactions (2005) (5)
- Anaphylactic reactions during anesthesia. (1992) (5)
- Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction (2021) (5)
- Perioperative experience with amrinone. (1992) (5)
- Abstract 16418: Reinitiation of Antithrombotic Therapy After Emergency Procedures or After an Uncontrolled or Life Threatening Bleeding Event. Initial Experience From the Re-verse Ad Trial (2015) (5)
- A Cost Analysis of the Impact of a New Intravenous Antihypertensive in Managing Perioperative Blood Pressure during Cardiac Surgery (2014) (5)
- Platelet Activation and Thrombosis in COVID-19 (2022) (5)
- Multicenter Trial of Desirudin for the Prophylaxis of Thrombosis (2013) (5)
- Hypercoagulability and coronavirus disease 2019–associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms (2020) (5)
- Antithrombin deficiency in special clinical syndromes--Part II: cardiovascular surgery. (1995) (5)
- Consensus statement: Hemostasis trial outcomes in cardiac surgery/mechanical support (2021) (5)
- Off-label use of recombinant human factor VIIa. (2014) (5)
- COVID-19–associated Coagulopathy (2021) (5)
- Intraoperative assessment of myocardial function (1994) (5)
- Inhaled Pulmonary Vasodilator Therapy in Adult Lung Transplant: A Randomized Clinical Trial. (2021) (5)
- How to manage anticoagulation during extracorporeal membrane oxygenation (2022) (5)
- Abstract 213: Effect of Idarucizumab on Intracranial Bleeding in Dabigatran-treated Patients: Initial Results From RE-VERSE AD (2016) (4)
- Adjuncts to Blood Component Therapies for the Treatment of Bleeding in the Intensive Care Unit. (2017) (4)
- Interference of thrombin in immunological assays for hirudin specific antibodies. (2012) (4)
- Clinical studies of erythrocyte outcomes and mortality: size really counts. (2013) (4)
- Effects of a plasma-derived C1 esterase inhibitor on hemostatic activation, clot formation, and thrombin generation (2014) (4)
- Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study (2021) (4)
- Skin Testing Performed in Individuals Cannot be Compared with Responses from Anaphylactic Patients (2008) (4)
- Tissue plasminogen activator and thrombin generation measurements using the Thrombinoscope. (2006) (3)
- Arterial and venous thrombosis complicating coronary artery bypass grafting after use of epoetin alfa-epbx (2020) (3)
- Restarting Therapeutic Anticoagulation After Elective Craniotomy for Patients with Chronic Atrial Fibrillation: A Review of the Literature. (2020) (3)
- Coagulation in trauma (2015) (3)
- Intracellular communication and immunothrombosis in sepsis (2022) (3)
- Effects of blood storage age on immune, coagulation, and nitric oxide parameters in transfused patients undergoing cardiac surgery (2019) (3)
- Prevention of Chronic Cerebral Vasospasm in Dogs with Milrinone. (1997) (3)
- Antiplatelet agents and bleeding after cardiac surgery. (2004) (3)
- How to interpret recent restrictive transfusion trials in cardiac surgery: More new data or new more data? (2019) (3)
- The authors reply. (2020) (3)
- Platelet-activating factor, PAF acetylhydrolase, and anaphylaxis. (2008) (3)
- Role of coagulation factor concentrates for reversing dabigatran-related anticoagulation. (2014) (3)
- 810-4 Pexelizumab, a C5 complement inhibitor, reduces 30-day mortality in patients undergoing coronary artery bypass surgery or receiving reperfusion therapy for acute myocardial infarction (2004) (3)
- EVALUATION OF HAEMONETICS CELL-SAVER PRODUCTS OBTAINED DURING CARDIOPULMONARY BYPASS (1984) (3)
- Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent. (2020) (3)
- 8 – General Approach to Anaphylactic Reactions (1992) (2)
- Anaphylaxis to chymopapain after antihistamine pretreatment. (1985) (2)
- The Role of Platelet Function Testing in Improving Clinical Outcomes (2020) (2)
- 6 – Common Anaphylactic and Anaphylactoid Reactions Seen by the Anesthesiologist (1992) (2)
- 2009 Anesthesia & Analgesia Guide for Authors (2009) (2)
- Invited commentary. (2012) (2)
- Protocolized hemostatic factor use in major thoracic aortic surgery. (2019) (2)
- Suppression of Fibrinolysis and Hypercoagulability, Severity of Hypoxemia, and Mortality in COVID-19 Patients: A Retrospective Cohort Study (2022) (2)
- Heparin-induced Thrombocytopenia: Perioperative Diagnosis and Management (2021) (2)
- Journal-related Activities and Other Special Activities at the 2018 American Society of Anesthesiologists Meeting (2017) (2)
- THE EFFECTS OF HEPARIN NEUTRALIZATION BY RECOMBINANT HUMAN PLATELET FACTOR 4 IN VITRO (1992) (2)
- Perioperative Thrombosis and Hemostasis (2020) (2)
- 4 Initial Experience With Idarucizumab in Dabigatran-Treated Patients Presenting With Acute Gastrointestinal Hemorrhage: Interim Results from the RE-VERSE AD Study (2015) (2)
- Interpreting recent clinical studies for COVID-19: A continual process with more new data (2021) (2)
- Blood Transfusion 1 Concepts of blood transfusion in adults (2013) (2)
- Argatroban "reversal" is caused by nonphysiologic stimulation of coagulation, not activated factor VII. (2010) (2)
- Understanding Potential Drug Side Effects: Can We Translate Molecular Mechanisms to Clinical Applications? (2017) (2)
- Intravenous epinephrine therapy in anaphylaxis. (1983) (2)
- IS THERE A DIFFERENCE BETWEEN FULL DOSE AND HALF DOSE APROTININ IN CHEST TUBE DRAINAGE FOLLOWING CARDIAC SURGERY (1992) (2)
- The effects of cardiopulmonary bypass on coagulation. (2013) (2)
- Bleeding and the new anticoagulants: strategies and concerns. (2015) (2)
- WHAT CONCENTRATION OF HEXADIMETHRINE AND METHYLENE BLUE IS REQUIRED FOR NEUTRALIZING HEPARIN AFTER CARDIOPULMONARY BYPASS (1994) (2)
- Morphological Changes in Blood Cells in a Rat Model of Heatstroke: A Pilot Study (2022) (1)
- Anaphylaxis and coronary disease. (1996) (1)
- Treat How I use fi brinogen replacement therapy in acquired bleeding (2015) (1)
- Chapter 3 – Cardiovascular Pharmacology (2007) (1)
- Chapter 30 – Bleeding, Hemostasis, and Transfusion Medicine (2007) (1)
- CHAPTER 3 – Mediators of Anaphylactic Reactions (1986) (1)
- Antifibrinolytics: e-Aminocaproic acid, Tranexamic Acid and Aprotinin (1996) (1)
- Pharmacologic and mechanical methods of discontinuing extracorporeal circulation in patients with heart failure. (1993) (1)
- Prothrombin Complex Concentrates and Cardiac Surgery (2015) (1)
- Abstract 15113: Idarucizumab in Dabigatran-Treated Patients Requiring Emergency Surgery or Intervention: Updated/Final Results From the RE-VERSE AD Study (2017) (1)
- The Predictive Value of the 4Ts and HEP Score at Recommended Cutoffs in Patients With Mechanical Circulatory Support Devices. (2022) (1)
- Anesthetic Inductions from Hexobarbital to Pentothal: Counting Down from 6 to 5? (2019) (1)
- Dabigatran-related coagulopathy: when can we assume the effect has "worn off"? (2014) (1)
- Management of urgent invasive procedures in patients treated with direct oral anticoagulants: An observational registry analysis. (2022) (1)
- Protamine reversal of heparin: a fishy practice? (2019) (1)
- Viscoelastic testing: an illustrated review of technology and clinical applications (2022) (1)
- 11 – Managing Sequelae in the Recovery Room and Intensive Care Unit (1992) (1)
- THE CARDIOVASCULAR AND HISTAMINE RELEASING PROPERTIES OF ORGANON 9487 (1998) (1)
- The risk of thromboembolic events with early intravenous 2‐ and 4‐g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double‐blind, placebo‐controlled, single‐center trial (2022) (1)
- Allergic reactions in anesthesia (2004) (1)
- Maintaining Hemostatic Balance in Treating Disseminated Intravascular Coagulation. (2019) (1)
- Health Care Resource Utilization in Patients Requiring Urgent Surgical/Interventional Management While Taking Dabigatran: Interim Results From the Re-Verse Ad Study (2016) (1)
- More on Venous Thrombosis during Spaceflight. (2020) (1)
- Chapter 27 – Postoperative Cardiovascular Management (2008) (1)
- Key Pathogenic Factors in Coronavirus Disease 2019–Associated Coagulopathy and Acute Lung Injury Highlighted in a Patient With Copresentation of Acute Myelocytic Leukemia: A Case Report (2021) (1)
- Novel oral anticoagulation agents: new drugs create new paradigms. (2014) (1)
- 2 – Initiation and Clinical Manifestations of Anaphylaxis (1992) (1)
- Three Factor Prothrombin Complex Concentrates in Cardiac Surgery: A Novel Algorithmic Approach to Perioperative Bleeding (2016) (1)
- Current Hematologic Issues in Cardiac Surgery and Cardiopulmonary Bypass (1998) (1)
- The Immunologic System: Perturbations Following Cardiopulmonary Bypass and the Problem of Infection in the Cardiac Surgery Patient (1995) (1)
- CHAPTER 12 – Human Physiologic Responses During Anaphylactic or Anaphylactoid Reactions (1986) (1)
- Thrombin Generation in Cardiac Versus Noncardiac Surgical Cohorts (2022) (1)
- Exposure and Outcome in practice: a retrospective cohort study between fibrinolytic suppression and hypercoagulability, the severity of hypoxemia, and mortality in COVID-19 patients. (2022) (1)
- Use of factor concentrates for the management of perioperative bleeding: reply (2018) (1)
- Trends in Anaesthesia and Critical Care (2015) (1)
- P3863Trauma victims requiring dabigatran reversal with idarucizumab in RE-VERSE AD (2018) (1)
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Antithrombin Supplementation in Patients at Risk for Antithrombin Deficiency After Cardiac Surgery (2022) (1)
- Cryoprecipitate transfusion in bleeding patients. (2020) (1)
- 7 – Preoperative Considerations of the Allergic Patient (1992) (1)
- Editorial comment: "coronary artery bypass grafting in 2 thrombophilic patients with protein s deficiency" and "fulminant intraoperative right heart and pulmonary artery thrombosis following prothrombin complex concentrate infusion after complex open heart surgery with cardiopulmonary bypass". (2014) (1)
- 284: INTEGRATED SAFETY ANALYSIS OF RECOMBINANT HUMAN ANTITHROMBIN ADMINISTRATION IN PATIENTS WITH HEPARIN RESISTANCE REQUIRING CARDIAC SURGERY AND CARDIOPULMONARY BYPASS (2012) (1)
- New Concepts in Anticoagulation and Reversal (1996) (1)
- Lack of Clinically Significant Interactions Between the Subcutaneously Administered Direct Thrombin Inhibitor Desirudin and Orally Administered Warfarin Upon the International Normalized Ratio. (2009) (1)
- Development of a novel blood-sparing agent in cardiac surgery: do we need another agent? (2014) (1)
- A.121 Vascular effects of histamine and acetylcholine in human internal mammary artery (1996) (1)
- Review article : Anaphylactic reactions during cardiac surgery (1991) (0)
- Faculty Opinions recommendation of 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. (2011) (0)
- Adult Perioperative Anesthesia: in The Requisites in Anesthesiology series. (2005) (0)
- Room B, 10/17/2000 9: 00 AM - 11: 00 AM (PS) Effects of Methylene Blue on Histamine-Induced Vasodilation in Human Mammary Artery A-172 (2000) (0)
- CLINICAL EXAMINATION DOES NOT PREDICT CARDIAC OUTPUT AFTER CARDIAC SURGERY (1988) (0)
- C URRENT OPINION Perioperative coagulation management in the intensive care unit (2013) (0)
- Anticoagulation Monitoring with Activated Partial ThromboPlastin Time and Anti-Xa Activity in Intensive Care Unit Patients: Interest of Thrombin Generation Assay (2022) (0)
- 544: PREDICTIVE VALUE OF 4T’S AND HEP SCORE FOR HIT WITH MECHANICAL CIRCULATORY SUPPORT (2020) (0)
- Public Health Surveillance : An Essential Tool to Evaluate the Effectiveness of Community CPR (2013) (0)
- Management of Chronically Anticoagulated Patients (2020) (0)
- Nevertheless, the importance of coagulation abnormalities should be emphasized in international sepsis guidelines (2022) (0)
- Abstracts of the 22nd Annual Meeting of the European Association of Cardiothoracic Anaesthesiologists. (2007) (0)
- CHAPTER 10 – Managing Sequelae in the Recovery Room and Intensive Care Unit (1986) (0)
- Title Page / Table of Contents / Imprint / Guidelines for Authors (2015) (0)
- Post Hoc Analysis of Desirudin Versus Enoxaparin for Thromboprophylaxis in High-Risk Patients Undergoing Elective Hip Replacement Surgery (2014) (0)
- IS MILRINONE EFFECTIVE AFTER EMERGENCE FROM CARDIOPULMONARY BYPASS IN PATIENTS UNDERGOING CARDIAC SURGERY (1994) (0)
- How to manage coagulopathies in critically ill patients (2023) (0)
- Blood Coagulation, Transfusion, and Conservation (2010) (0)
- Perioperative coagulation management: Evolving strategies. (2018) (0)
- Invited commentary. (2007) (0)
- CHAPTER 11 – Respiratory Management Following Anaphylaxis (1986) (0)
- Letter to the Editor (2016) (0)
- CHAPTER 4 – Systems That Can Generate Immediate Hypersensitivity Reactions Independent of IgE (1986) (0)
- Allergy and Anaphylaxis in Trauma (2007) (0)
- 5 Hemostasis and Cardiopulmonary Bypass (0)
- The authors reply (2020) (0)
- Renal Dysfunction and Arrhythmia Association in Patients Receiving Milrinone After Cardiac Surgery. (2022) (0)
- TITLE: Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction RUNNING TITLE: Cerebrospinal Fluid Proteome Changes after Surgery AUTHORS: (2021) (0)
- Effets compares de la prostaglandine E1 et de la nitroglycerine sur l'artere mammaire interne humaine. (1996) (0)
- SUPPLEMENTAL ANTITHROMBIN IMPROVES ANTICOAGULATION DURING PRIMARY CORONARY ARTERY BYPASS GRAFTING (1998) (0)
- Antiplatelets to Anticoagulants : Making Sense of the Coagulation Cocktails (2008) (0)
- Abstract 11648: Bleeding in Patients Receiving Inhaled Pulmonary Vasodilators for Heart Failure Operations (2021) (0)
- Evaluation of the REG1 Anticoagulant System Using Thrombelastography and Thrombin Generation Assay. (2007) (0)
- 12 – Human Physiologic Responses During Anaphylactic or Anaphylactoid Reactions (1992) (0)
- Optimal Tranexamic Acid Dosing Regimen in Cardiac Surgery: What Are the Missing Pieces? (2021) (0)
- In Reply. (2016) (0)
- The Contact Activation System: Problems and Paradoxes for Cardiac Anesthesiologists. (2020) (0)
- Evaluation and management of oral anticoagulant bleeding: quid didicimus? (what have we learned?). (2023) (0)
- [Chronic influence of carbon monoxide on the nervous system]. (1973) (0)
- Journal-related Activities and Other Special Activities at the 2016 American Society of Anesthesiologists Annual Meeting (2010) (0)
- Inhibition of Complement Activation by Pexelizumab Reduces Death and Myocardial Infarction in Cardiac Surgical Patients With Selected Risk Profiles: Results from the International Multi-Center PRIMO-CABG Study (2004) (0)
- Blood and Coagulation (2019) (0)
- Is the radial artery a better conduit for coronary revascularization (1998) (0)
- 229: IMPROVING MANAGEMENT OF ACUTE HYPERTENSION SUCCESS OF ONLINE CME (2019) (0)
- Chapter 35 – Blood and Coagulation (2013) (0)
- Antiplatelet agents and bleeding after cardiac surgery. Authors' reply (2004) (0)
- APROTININ STUDIES IN CHILDREN (2004) (0)
- Communication from the Scientific Standardization Committees of the International Society on Thrombosis and Haemostasias on vascular endothelium-related biomarkers in disseminated intravascular coagulation. (2022) (0)
- VTE Prophylaxis with Desirudin in Patients with Thrombocytopenia: Insights From the DESIRABLE Trial, (2011) (0)
- Comprar Inflammation, Hemostasis, An Issue of Hematology/Oncology Clinics | Jerrold Levy | 9781416043225 | Saunders (2007) (0)
- 175: MILRINONE DOSING CHARACTERISTICS AND ARRHYTHMIA ASSOCIATION AFTER CARDIAC SURGERY (2022) (0)
- THE EFFECT OF FENOLDOPAM, A DA1-RECEPTOR AGONIST ON HUMAN INTERNAL MAMMARY ARTERY (1998) (0)
- Anaphylactic and Anaphylactoid Reactions in the Surgical Patient (0)
- Allergic Reactions and the Intraoperative Use of Foreign Substances (1985) (0)
- In Response. (2017) (0)
- Anticoagulation in adult patients supported with extracorporeal membrane oxygenation: guidance from the Scientific and Standardization Committees on Perioperative and Critical Care Haemostasis and Thrombosis of the International Society on Thrombosis and Haemostasis. (2022) (0)
- Epinephrine-induced effects on cerebral microcirculation and oxygenation dynamics using multimodal monitoring and functional photoacoustic microscopy. (2023) (0)
- Perioperative Anaphylaxis (2022) (0)
- Inhaled Selective Pulmonary Vasodilators for Adult Lung Transplantation (2021) (0)
- CHAPTER 8 – Pharmacologic Therapy for Anaphylaxis (1986) (0)
- In Vitro Treatment of Extracorporeal Membrane Oxygenation Coagulopathy with Recombinant von Willebrand Factor or Lyophilized Platelets. (2022) (0)
- DOES WARFARIN INCREASE BLEEDING IN PATIENTS UNDERGOING HEART TRANSPLANTATION (1999) (0)
- Iconographies supplémentaires de l'article : Diagnosis and management of heparin-induced thrombocytopenia (2020) (0)
- Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies (2021) (0)
- Edoxaban in the secondary prevention of VTE. (2016) (0)
- Can We Use Viscoelastic Testing to Evaluate Microvascular Dysfunction in Acute Myocardial Infarction? (2021) (0)
- Room C, 10/17/2000 2: 00 PM - 4: 00 PM (PS) Reversal of Amiodarone-Induced Vasodilation by Nitric Oxide Pathway Inhibitors A-231 (2000) (0)
- ECMO Outcomes, Transfusions, and Hemostatic Management: Quo Vadis? (2022) (0)
- Prevention and management of bleeding (2004) (0)
- CONTAMINATION REDUCTION DURING CENTRAL VENOUS CANNULATION: DOES IT MAKE A DIFFERENCE? (1985) (0)
- In reply. (2014) (0)
- ID: 196 The interaction of active-site blocked thrombin and bivalirudin (2006) (0)
- CHAPTER 9 – A Therapeutic Protocol for the Management of Acute Anaphylaxis (1986) (0)
- AN IMPROVED TECHNIQUE FOR CONTAMINATION REDUCTION DURING CENTRAL VENOUS CANNULATION (1984) (0)
- Concentration-Dependent Dual Role of Thrombin in Protection of Cultured Rat Cortical Neurons (2015) (0)
- 1 – Anaphylaxis, Allergy, and Immunology (1992) (0)
- Room B, 10/17/2000 2: 00 PM - 4: 00 PM (PS) Aprotinin Use in Patients Taking Inhibitors of Angiotensin Converting Enzyme (ACEI) A-199 (2000) (0)
- Transfusion Requirements and Outcomes In the Cohort of Patients Undergoing Isolated CABG Treated with Prasugrel or Clopidogrel: TRITON-TIMI 38 Data Analysis. (2010) (0)
- Keynote Lecture 1 (2018) (0)
- CHAPTER 7 – General Approach to Anaphylactic Reactions (1986) (0)
- What are the current practices of anticoagulation and it's monitoring for cardiac surgery in the United States? (1995) (0)
- Ischemic Preconditioning and the Role of Antifibrinolytic Drugs: Translation From Bench to Bedside. (2018) (0)
- CHAPTER 2 – IgE Anaphylaxis (1986) (0)
- In Response. (2017) (0)
- Anesthetic Pharmacology: Drug allergy and treatment (2013) (0)
- Heparin‐Induced Thrombocytopenia (2014) (0)
- In Response. (2020) (0)
- Pathogenesis of CPB-induced SIRS (2012) (0)
- A Novel Method To Measure Activated Clotting Times during Aprotinin Therapy: [2002][A-133] (2002) (0)
- Abstract 16210: Protocolized Hemostatic Factor Use in Major Thoracic Aortic Surgery (2017) (0)
- Effects of Drugs on the Vascular System (1996) (0)
- Viscoelastic testing to assess the effects of rapid fibrinogen concentrate administration after cardiopulmonary bypass: insights from the REPLACE study (2021) (0)
- CHAPTER 1 – Anaphylaxis, Allergy, and Immunology (1986) (0)
- The Effect of Glycoprotein Ib Blockade on the Thromboelastogram: [2002][A-131] (2002) (0)
- Pitfalls in Diagnosing Vaccine-Induced Immune Thrombotic Thrombocytopenia. (2021) (0)
- Faculty Opinions recommendation of Comparison of dopamine and norepinephrine in the treatment of shock. (2010) (0)
- Incidence of hypersensitivity reactions. Commentary (1998) (0)
- HEMATOLOGY/ONCOLOGY CLINICS (2007) (0)
- Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis. (2023) (0)
- Heated Humidified Breathing Circuit Rewarming in Hypothermic Patients Post-Cardiopulmonary Bypass-Pilot Study. (2021) (0)
- C URRENT OPINION Managing clotting: a North American perspective (2012) (0)
- Cerebrospinal Fluid Proteomic Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction (2020) (0)
- A Novel Method of Evaluating Heparin Dose Responses with Aprotinin: The Sonoclot Aprotinin Stable Cuvette: [2002][A-134] (2002) (0)
- NON VITAMIN K ORAL ANTICOAGULANTS ARE NOT ASSOCIATED WITH INCREASED RISK OF PERIOPERATIVE BLEEDING IN PATIENTS UNDERGOING CARDIAC SURGERY (2019) (0)
- Editorial Comment: Factor XIII: One More Critical Factor for Hemostasis. (2015) (0)
- Anticoagulation ( DESIRABLE ) Multicenter Trial of Desirudin for the Prophylaxis of Thrombosis : An Alternative to Heparin-Based (2012) (0)
- Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021) (2021) (0)
- Coagulopathy and Bleeding Management for Aortic Dissection Surgery (2021) (0)
- Effects of vecuronium-induced histamineN-methyltransferase inhibition on cutaneous responses to histamine (1992) (0)
- A new SOFA score calculation to improve the predictive performance for mortality in sepsis-associated disseminated intravascular coagulopathy patients. (2020) (0)
- Perceptions about rapid warfarin reversal with fresh frozen plasma to reduce the INR: A novel survey methodology (2011) (0)
- Acknowledgement to Reviewers (2016) (0)
- Effets de differents traitements vasodilatateurs sur un modele in vitro de vasoconstriction pulmonaire (1996) (0)
- Prévention du risque thromboembolique veineux et surveillance de l’hémostase chez les patients hospitalisés pour COVID-19 : propositions réactualisées (avril 2021). Groupe d’intérêt en hémostase périopératoire (GIHP) et groupe d’étude sur l’hémostase et la thrombose (GFHT) (2021) (0)
- CLINICAL MANAGEMENT OF URTICARIA AND ANAPHYLAXIS (1994) (0)
- Faculty Opinions recommendation of High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients. (2010) (0)
- 10 – Management of Anaphylaxis (1992) (0)
- 9 – Pharmacologic Therapy for Anaphylaxis (1992) (0)
- 5 – Nonimmunologic (Pharmacologic) Histamine Release (1992) (0)
- WHOLE BLOOD HISTAMINE RELEASE BY PROTAMINE (1984) (0)
- HBOC-201 IS MORE EFFECTIVE THAN RED BLOOD CELLS (RBC) IN TREATING HEMODYNAMIC INSTABILITY IN PATIENTS FOLLOWING CARDIOPULMONARY BYPASS (CPB) SURGERY* (1999) (0)
- RE: The prothrombin time ratio is not a more effective marker for evaluating sepsis‐induced coagulopathy than fibrin‐related markers: Response to the Letter‐to‐the‐Editor by Dr Wada (2020) (0)
- Effects of complement inhibition by pexelizumab on myocardial infarction or death following cardiac surgery. A combined analysis of two multicenter, placebo-controlled, randomized trials (2004) (0)
- PROTAMINE-SPECIFIC IgE ANTIBODIES AS PREDICTORS OF ADVERSE REACTIONS IN INSULIN DEPENDENT DIABETIC PATIENTS (1988) (0)
- Chapter 77 – Perioperative Hypertension (2007) (0)
- Abstract 124: Can High-Quality Interventional Trials be Performed in Cardiac Surgery Patients With Excessive Bleeding Despite Conventional Blood Transfusion Therapy? (2010) (0)
- What Can American Anesthesiologists Learn From European Anesthesiologists (2015) (0)
- Abstract 17725: Frequency and Prognostic Importance of Troponin and CK-MB Elevations Following Coronary Artery Bypass Grafting: An Analysis from PRIMO I and PRIMO II (2012) (0)
- Perioperative Considerations in Management of the Severely Bleeding Coagulopathic Patient (2023) (0)
- A Laboratory Test to Detect Antibodies to Protamine (1987) (0)
- What's fishy about protamine? Clinical use, adverse reactions, and potential alternatives. (2023) (0)
- Anaesthesia Review 3 (1987) (0)
- Plasma Tryptase in Nonimmunologic Reactions (2001) (0)
- Inflammation, coagulation, and cellular injury in heat-induced shock (2023) (0)
- Contributors (2019) (0)
- Management of surgical low cardiac output syndrome (1990) (0)
- Applications of Aprotinin in Cardiac Surgery (2004) (0)
- ANESTHESIA FOR THORACIC SURGERY (1988) (0)
- Differential Effects of Hirudin and Heparin on the Whole Blood Clot Formation: [2002][A-535] (2002) (0)
- Heparin Dose , and Type and Dose of Heparin Reversal Agent for Each Study Patient (2012) (0)
- Room C, 10/16/2000 9: 00 AM - 11: 00 AM (PS) Clopidogrel on Bleeding and Transfusion Requirements after Coronary Bypass Graft Surgery A-317 (2000) (0)
- Supplementary fibrinogen in the management of bleeding: re-evaluation of data from clinical trials. (2017) (0)
- Position du GIHP sur les tests viscoélastiques : quelle place pour quelle indication en situation hémorragique ? (2018) (0)
- Faculty Opinions recommendation of A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor. (2008) (0)
- Communication from the SSC of the ISTH on vascular endothelium-related biomarkers in DIC (2022) (0)
- Factor concentrates for perioperative bleeding: old drugs with new approaches. (2015) (0)
- The official scientific journal of the International Anesthesia Research Society ® , The Society of Cardiovascular Anesthesiologists, the Society for Pediatric Anesthesia, the Society for Ambulatory Anesthesia, the International Society for Anaesthetic Pharmacology, the Society for Technology in Ane (2008) (0)
- Continuous thrombin generation for monitoring phenprocoumon anticoagulation: P-89 (2007) (0)
- Direct Oral Anticoagulants (0)
- CHAPTER 6 – Preoperative Considerations in the Patient at Risk (1986) (0)
- CHAPTER 5 – Common Anaphylactic and Anaphylactoid Reactions the Anesthesiologist Sees (1986) (0)
- Dr. Levy replies (1989) (0)
- m REVIEW ARTICLE (1999) (0)
- Anaphylaxis, Allergy, and Adverse Drug Reactions: Important Considerations for Perioperative Management (2013) (0)
- Commentary: Patient blood management in the era of coronavirus disease 2019—is anything really different? (2021) (0)
- 3 – Mediators of Anaphylactic Reactions (1992) (0)
- Original articleGeneral thoracicInvited commentary (2007) (0)
This paper list is powered by the following services:
Other Resources About Jerrold Levy
What Schools Are Affiliated With Jerrold Levy?
Jerrold Levy is affiliated with the following schools:
